These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 20587609)
1. The role of the amino-terminal domain in the interaction of unliganded peroxisome proliferator-activated receptor gamma-2 with nuclear receptor co-repressor. Suzuki S; Sasaki S; Morita H; Oki Y; Turiya D; Ito T; Misawa H; Ishizuka K; Nakamura H J Mol Endocrinol; 2010 Sep; 45(3):133-45. PubMed ID: 20587609 [TBL] [Abstract][Full Text] [Related]
2. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation. Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma. Shipley JM; Waxman DJ Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Xu HE; Stanley TB; Montana VG; Lambert MH; Shearer BG; Cobb JE; McKee DD; Galardi CM; Plunket KD; Nolte RT; Parks DJ; Moore JT; Kliewer SA; Willson TM; Stimmel JB Nature; 2002 Feb; 415(6873):813-7. PubMed ID: 11845213 [TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma in malignant diseases. Wang T; Xu J; Yu X; Yang R; Han ZC Crit Rev Oncol Hematol; 2006 Apr; 58(1):1-14. PubMed ID: 16388966 [TBL] [Abstract][Full Text] [Related]
6. The oligomeric state of thyroid receptor regulates hormone binding kinetics. Cunha Lima ST; Rodrigues ED J Endocrinol; 2011 Jul; 210(1):125-34. PubMed ID: 21508093 [TBL] [Abstract][Full Text] [Related]
7. Identification of the putative MAP kinase docking site in the thyroid hormone receptor-beta1 DNA-binding domain: functional consequences of mutations at the docking site. Lin HY; Zhang S; West BL; Tang HY; Passaretti T; Davis FB; Davis PJ Biochemistry; 2003 Jun; 42(24):7571-9. PubMed ID: 12809513 [TBL] [Abstract][Full Text] [Related]
8. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity. Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732 [TBL] [Abstract][Full Text] [Related]
9. Structural insight into peroxisome proliferator-activated receptor gamma binding of two ureidofibrate-like enantiomers by molecular dynamics, cofactor interaction analysis, and site-directed mutagenesis. Pochetti G; Mitro N; Lavecchia A; Gilardi F; Besker N; Scotti E; Aschi M; Re N; Fracchiolla G; Laghezza A; Tortorella P; Montanari R; Novellino E; Mazza F; Crestani M; Loiodice F J Med Chem; 2010 Jun; 53(11):4354-66. PubMed ID: 20462215 [TBL] [Abstract][Full Text] [Related]
10. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity. Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614 [TBL] [Abstract][Full Text] [Related]
12. Thyroid-hormone-dependent negative regulation of thyrotropin beta gene by thyroid hormone receptors: study with a new experimental system using CV1 cells. Nakano K; Matsushita A; Sasaki S; Misawa H; Nishiyama K; Kashiwabara Y; Nakamura H Biochem J; 2004 Mar; 378(Pt 2):549-57. PubMed ID: 14611644 [TBL] [Abstract][Full Text] [Related]
13. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315 [TBL] [Abstract][Full Text] [Related]
14. Site-directed mutagenesis to study the role of specific amino acids in the ligand binding domain of PPARs. Mitro N; Gilardi F; Giudici M; Godio C; Scotti E; Crestani M Methods Mol Biol; 2013; 952():137-44. PubMed ID: 23100229 [TBL] [Abstract][Full Text] [Related]
15. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. Schaufele F; Carbonell X; Guerbadot M; Borngraeber S; Chapman MS; Ma AA; Miner JN; Diamond MI Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9802-7. PubMed ID: 15994236 [TBL] [Abstract][Full Text] [Related]